source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

New Director for One Nucleus

Linda Summerton, PhD, Chief Executive of Immodulon and a Senior Partner with TranScrip Partners, has been appointed as Director of One Nucleus. Dr Summerton has more than 25 years’ experience in the global pharmaceutical industry and has worked in large…

Isogenica grants antibody library licence to Maverick Therapeutics

Isogenica Ltd has completed a new licensing deal for its llamdA ™ VHH single-domain antibody libraries with Maverick Therapeutics, a private start-up biotechnology company utilising a proprietary T-cell engagement format for the development of novel T-cell redirection therapies. Isogenica has…

Sci-Tech Daresbury opens TECHSPACE ONE

UK National Science and Innovation Campus Sci-Tech Daresbury has opened TECHSPACE ONE, a three-storey laboratory and office building providing accommodation for growing companies in the biomedical, materials, process technology and clean technology sectors. Situated alongside the Daresbury Expressway in Runcorn,…

Enamine and Actelion expand drug discovery collaboration

Chemical building block producer Enamine Ltd is expanding its early drug discovery collaboration with Actelion Pharmaceuticals (Actelion) in which it provides library synthesis and medicinal chemistry services through the application of its extensive capabilities for the synthesis of advanced screening…

Pfizer joins Milner Therapeutics Consortium

Pfizer Inc has become a partner in the Milner Therapeutics Consortium, which was established in 2015 as a ‘match-making’ service for researchers based in Cambridge, UK-based academic institutions and pharmaceutical companies. The Consortium enables the efficient transfer of materials between…

ECI Partners invests in Edenhouse Solutions

Edenhouse Solutions, a Birmingham, UK based SAP consultancy, is to receive funding from private equity firm ECI Partners. The Edenhouse board will retain its controlling interest in the company and will be joined by Richard Chapman from ECI and Chairman…

Co-Formulate to develop paediatric formulations for Proveca

Co-Formulate Limited, a division of Quotient Clinical, has been contracted by Proveca Ltd to perform paediatric formulation development work on a number of off-patent compounds in an extension to the companies’ existing collaboration agreement. The new agreement follows Co-Formulate’s successful…

Synpromics and Adverum Biotechnologies expand research collaboration

Gene control specialist company Synpromics and Adverum Biotechnologies have expanded their research collaboration which began in December 2015. Their initial collaboration focused on using Synpromics technology to develop promoters for the treatment of eye diseases and has produced promising early…
Subscribe to this RSS feed